600285 羚锐制药
2024/06 - 中期
人民币(K¥)
与去年末期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)

非流动资产
长期股权投资73,1192.60%71,26871,652117,10398,581
投资性房地产0--0000
固定资产610,787-4.02%636,362696,816697,992727,256
在建工程2,444-15.11%2,8791,92424,7752,775
无形资产204,3040.89%202,503203,646236,946235,040
商誉0--0000
其他非流动资产1,723,76436.81%1,259,973862,191585,344477,564
2,614,41720.31%2,172,9851,836,2291,662,1601,541,216

流动资产
货币资金726,897-51.50%1,498,8951,179,296801,242732,317
应收账款310,92820.33%258,403195,973172,906145,720
存货439,159-6.03%467,353486,411428,389331,412
其他流动资产622,57166.34%374,282646,712728,700707,092
2,099,555-19.21%2,598,9332,508,3932,131,2371,916,541

流动负债
短期借款18,598-86.83%141,22193,811126,33820,000
应付票据0--0000
应付帐款91,17258.90%57,37868,02178,01178,809
其他流动负债1,829,2927.51%1,701,5611,550,1161,233,299967,449
1,939,0622.05%1,900,1591,711,9481,437,6481,066,257
流动资产净值160,492-77.03%698,773796,444693,589850,284
资产总额减流动负债2,774,909-3.37%2,871,7582,632,6732,355,7492,391,499

非流动负债
长期借款0--0000
应付债券0--0000
其他非流动负债63,928-12.50%73,06174,31269,25269,345
63,928-12.50%73,06174,31269,25269,345

总权益
    实收股本567,140-0.00%567,144567,459567,759567,809
    储备项目2,136,071-3.95%2,223,8971,983,3551,711,1521,744,915
股东权益2,703,211-3.15%2,791,0412,550,8142,278,9112,312,724
非控股权益7,7701.49%7,6567,5477,5869,430